Global Pruritus Therapeutics Market Valuation and Growth Prospects: $15.7 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the pruritus therapeutics market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Pruritus Therapeutics Market Size?

The pruritus therapeutics market size has seen steady expansion in recent years. It is anticipated to increase from $11.89 billion in 2024 to $12.38 billion in 2025, achieving a compound annual growth rate (CAGR) of 4.1%. The expansion observed in the past can be attributed to an increase in the occurrence of pruritus, various contributing causes and conditions, a growing elderly population, and a focus on enhancing the quality of life for patients.

The pruritus therapeutics market is projected to experience substantial expansion in the coming years. This market is anticipated to reach “$15.7 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.1%. This projected growth during the forecast period is fueled by several factors, including an expanding understanding of pruritus pathophysiology, the emergence of innovative drug formulations and delivery methods, a concentrated focus on personalized medicine, a surge in dermatological research and development, rising awareness and diagnosis rates, and an increasing appeal for botanical and herbal remedies. Key trends expected within this period involve the creation of itch-specific receptor agonists and antagonists, a market-wide focus on individualized therapeutic strategies, the incorporation of technology into itch monitoring and management, and collaborative efforts for cross-disciplinary research.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11907&type=smp

What Core Market Drivers Are Expanding The Pruritus Therapeutics Industry?

An anticipated increase in dermatological conditions is projected to boost the expansion of the pruritus therapeutics market. These disorders encompass conditions affecting the skin, hair, nails, and mucous membranes, spanning from common issues like acne and eczema to more severe ones such as skin cancer and fungal infections. The specific etiology of itching frequently dictates the selection of pruritus treatments for various skin-related ailments. Such treatments include local applications, softening agents and hydrating creams, immune-suppressing drugs, and antipruritic medicines. As an illustration, in January 2024, the American Cancer Society, a US-based non-profit dedicated to eradicating cancer, projected 108,270 reported skin cancer cases, signifying a 3.2% increase from the 104,930 cases documented in 2023. Consequently, the growing occurrence of dermatological conditions is fueling the expansion of the pruritus therapeutics market.

What Segment Insights Are Highlighted In The Pruritus Therapeutics Market Report?

The pruritus therapeutics market covered in this report is segmented –

1) By Product: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressants, Calcineurin Inhibitors, Other Products

2) By Route Of Administration: Oral, Parenteral, Topical

3) By Disease Type: Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types

4) By End-User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids

2) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines

3) By Local Anesthetics: Topical Local Anesthetics

4) By Counterirritants: Menthol-Based Products, Camphor-Based Products

5) By Immunosuppressants: Topical Immunosuppressants, Systemic Immunosuppressants

6) By Calcineurin Inhibitors: Tacrolimus Ointment, Pimecrolimus Cream

7) By Other Products: Moisturizers And Emollients, Antipruritic Herbal Remedies, Combination Therapies

Which Notable Trends Are Transforming The Pruritus Therapeutics Market Outlook?

Major companies operating in the pruritus therapeutics market are concentrating on developing targeted therapies for rare diseases and specific patient populations, utilizing methods such as non-systemic ileal bile acid transport inhibitors to deliver personalized medicine that addresses unfulfilled medical needs. A non-systemic ileal bile acid transport inhibitor functions by targeting bile acid absorption within the intestine without substantially affecting the body’s overall systemic circulation, thereby mitigating potential side effects. As an illustration, in June 2023, Ipsen, a France-based pharma company, secured approval from the Food and Drug Administration (FDA), a US-based federal agency of the Department of Health and Human Services, for Bylvay (odevixibat) to treat cholestatic pruritus in individuals aged 12 months and older suffering from Alagille syndrome (ALGS). Bylvay, administered once daily, is a non-systemic ileal bile acid transport inhibitor (IBATi) with minimal systemic exposure, representing the initial drug sanctioned for cholestatic pruritus caused by progressive familial intrahepatic cholestasis (PFIC) in the U.S. This medication had previously obtained approval for PFIC treatment in Europe and is currently accessible by prescription for eligible ALGS patients.

Which Firms Are Driving Innovation Within The Pruritus Therapeutics Market?

Major companies operating in the pruritus therapeutics market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc. , Bausch Health Companies Inc., Galderma Laboratories LP, Cipla Limited, LEO Pharma AS, Cara Therapeutics Inc., GlaxoSmithKline Plc, Novan Inc., Escient Pharmaceuticals Inc., Nerre Therapeutic Ltd., EPI Health LLC, Trevi Therapeutics Inc., Evelo Biosciences, Toray Medical Co. Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report

What Regional Trends Are Shaping Growth In The Pruritus Therapeutics Market?

North America was the largest region in the pruritus treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pruritus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=11907&type=smp

Browse Through More Reports Similar to the Global Pruritus Therapeutics Market 2025, By The Business Research Company

Blood Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Rituximab Biosimilar Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rituximab-biosimilar-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795